Cardiac Biomarkers and Risk of Atherosclerotic Cardiovascular Disease in Patients with CKD.

Benjamin Lidgard Leila R ZelnickAmanda H AndersonHarold FeldmanAlan S Go Jiang HeMayank KansalMadhumita Jena MohantyRupal MehtaMichael G ShlipakElsayed Z Soliman Matthew R Weir Nisha Bansalnull null

Published in: Kidney360 (2022)

NT-proBNP, hsTnT, GDF-15, and sST2 were significantly associated with incident atherosclerotic cardiovascular disease in patients with CKD. These associations may highlight important mechanisms for the development of atherosclerotic disease in CKD.

Keyphrases

cardiovascular disease
chronic kidney disease
type diabetes
cardiovascular events
cardiovascular risk factors
left ventricular
heart failure
metabolic syndrome